Gilead to transfer technology Dr. Reddy's Laboratories Ltd has entered into a non-exclusive Licensing Agreement with Gilead Sciences Inc on 13 June 2020, getting the right to register, manufacture and sell Gilead’s investigational drug, Remdesivir, a potential treatment for Covid-19,...
Read moreDetails











